Bio-Rad Laboratories (BIO) Operating Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Operating Expenses for 18 consecutive years, with $273.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 1.86% year-over-year to $273.2 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 0.68% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 0.9% from the prior year.
• Operating Expenses was $273.2 million for Q2 2026 at Bio-Rad Laboratories, down from $275.3 million in the prior quarter.
• Over five years, Operating Expenses peaked at $300.5 million in Q1 2023 and troughed at $244.7 million in Q3 2023.
• A 5-year average of $275.1 million and a median of $276.6 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses dropped 14.52% in 2022 and increased 19.07% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $278.4 million in 2022, then decreased by 2.66% to $271.0 million in 2023, then gained by 4.65% to $283.6 million in 2024, then gained by 2.72% to $291.3 million in 2025, then slipped by 6.21% to $273.2 million in 2026.
• The last three Operating Expenses figures came in at $273.2 million (Q2 2026), $275.3 million (Q1 2026), and $291.3 million (Q4 2025), per Business Quant data.